Immuno-Oncology Platform to Enable Discovery from Target to Drug

Continue Reading

Enabling Technologies for Targeted Protein Degradation Webinar

Continue Reading

New Platform from Target-to-Hit

Continue Reading

Enabling Technologies For Bifunctional Molecule Discovery And Characterization

Continue Reading

Cancer Immunotherapy and the Application of In Vitro Immunoassays in Drug Development

Continue Reading

Novel Peptide Hit Identification and Lead Generating Strategies for Drug Discovery

Continue Reading

Optimizing Drug Discovery Pipelines with Biophysical Methods

Continue Reading

Validation of GVHD in mouse model for preclinical efficacy screen

AACR Annual meeting 2021 Na Xu, Ya Zhang, Rou Xie, Lijun Jia, Yingying Cai, Qing Lin Oncology and Immunology Unit,...

Continue Reading

Engineered cell line panel complemented with in vivo models to enable next-generation target therapy discovery...

 AACR Annual meeting 2021   Authors: Zhixiang Zhang1, Feifei Fan2, Xiaohe Shi2, Xiangyang Zuo2, Qingyang Gu2, Qunsheng Ji1. 1 WuXi AppTec,...

Continue Reading